A 2.3m sq ft biomedical campus in Cambridge that will house a major research laboratory for the Medical Research Council was given the go-ahead this week.
Cambridge City Council approved planning permission for the 70 acre scheme – known as the Cambridge Biomedical Campus – which is located next to Addenbrooke’s Hospital on Monday.
It is being developed by Countryside Properties, which is owned jointly by the Cherry family and the Bank of Scotland, US REIT Liberty Property Trust and Cambridge University Hospitals NHS Foundation Trust.
Research and Development
The joint venture plans a scheme comprising 1.7m sq ft of biomedical research and development space with 600,000 sq ft of clinical space to accommodate the expansion of the existing Addenbrooke’s Hospital.
The campus has already secured a significant deal at the site after it sold 10 acres of land to the Medical Research Council to develop a 290,000 sq ft Laboratory of Molecular Biology, designed by RMJM Architects.
The famous heart and lung specialist hospital Papworth has also said it would relocate to the site.
Existing facilities at the site occupied by research institutes such as the Cancer Research UK Centre and the Wellcome Trust Clinical Research Facility will be incorporated into the scheme.
For more, see Friday's Property Week.